CN101429514A - 一种双羰基还原酶、其基因及其应用 - Google Patents
一种双羰基还原酶、其基因及其应用 Download PDFInfo
- Publication number
- CN101429514A CN101429514A CNA2007101353918A CN200710135391A CN101429514A CN 101429514 A CN101429514 A CN 101429514A CN A2007101353918 A CNA2007101353918 A CN A2007101353918A CN 200710135391 A CN200710135391 A CN 200710135391A CN 101429514 A CN101429514 A CN 101429514A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- carbonyl reduction
- gene
- reduction enzyme
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 44
- 108090000790 Enzymes Proteins 0.000 title claims description 75
- 102000004190 Enzymes Human genes 0.000 title claims description 70
- 230000009467 reduction Effects 0.000 title claims description 62
- 238000006243 chemical reaction Methods 0.000 claims abstract description 16
- 239000002773 nucleotide Substances 0.000 claims abstract description 6
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 3
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 125000003118 aryl group Chemical group 0.000 claims description 12
- 230000003197 catalytic effect Effects 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 125000002521 alkyl halide group Chemical group 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 150000001728 carbonyl compounds Chemical class 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- -1 dicarbonyl compound Chemical class 0.000 abstract description 3
- 125000004989 dicarbonyl group Chemical group 0.000 abstract 4
- 238000006722 reduction reaction Methods 0.000 description 57
- 239000000047 product Substances 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 239000000758 substrate Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 9
- 230000014509 gene expression Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 8
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 8
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000002018 overexpression Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000009182 swimming Effects 0.000 description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000013016 damping Methods 0.000 description 3
- 239000013604 expression vector Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 102220023258 rs387907548 Human genes 0.000 description 3
- 241000588625 Acinetobacter sp. Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- KGVHCTWYMPWEGN-FSPLSTOPSA-N Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CN KGVHCTWYMPWEGN-FSPLSTOPSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010020056 Hydrogenase Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 230000002210 biocatalytic effect Effects 0.000 description 2
- 102220369447 c.1352G>A Human genes 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000000707 stereoselective effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 241000589291 Acinetobacter Species 0.000 description 1
- 241000588624 Acinetobacter calcoaceticus Species 0.000 description 1
- 108010031132 Alcohol Oxidoreductases Proteins 0.000 description 1
- 102000005751 Alcohol Oxidoreductases Human genes 0.000 description 1
- DVUFTQLHHHJEMK-IMJSIDKUSA-N Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O DVUFTQLHHHJEMK-IMJSIDKUSA-N 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000594182 Sarcophaga sigma Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical class CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000002205 phenol-chloroform extraction Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 108010046845 tryptones Proteins 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101353918A CN101429514B (zh) | 2007-11-08 | 2007-11-08 | 一种双羰基还原酶、其基因及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007101353918A CN101429514B (zh) | 2007-11-08 | 2007-11-08 | 一种双羰基还原酶、其基因及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101429514A true CN101429514A (zh) | 2009-05-13 |
CN101429514B CN101429514B (zh) | 2011-06-15 |
Family
ID=40645152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007101353918A Expired - Fee Related CN101429514B (zh) | 2007-11-08 | 2007-11-08 | 一种双羰基还原酶、其基因及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101429514B (zh) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011066755A1 (zh) * | 2009-12-01 | 2011-06-09 | Chen Yijun | (3r,5s)-二羟基-6-苄氧基己酸乙酯的合成 |
CN101665811B (zh) * | 2009-09-04 | 2012-09-05 | 陈依军 | 一种制备s-2-羟基-4-苯基丁酸乙酯的方法 |
CN103937759A (zh) * | 2014-05-06 | 2014-07-23 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
CN103937761A (zh) * | 2014-05-06 | 2014-07-23 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
CN103937760A (zh) * | 2014-05-06 | 2014-07-23 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
CN104560907A (zh) * | 2014-12-19 | 2015-04-29 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶突变体及其应用 |
WO2015168999A1 (zh) * | 2014-05-09 | 2015-11-12 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶突变体及其应用 |
WO2015168867A1 (zh) * | 2014-05-06 | 2015-11-12 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
WO2015168868A1 (zh) * | 2014-05-06 | 2015-11-12 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
WO2015168866A1 (zh) * | 2014-05-06 | 2015-11-12 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
CN109503542A (zh) * | 2019-01-04 | 2019-03-22 | 浙江宏元药业股份有限公司 | 一种阿托伐他汀钙中间体及其制备方法和应用 |
CN114525264A (zh) * | 2020-11-23 | 2022-05-24 | 台州华酶生物科技有限公司 | 一种高活力羰基还原酶突变体及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5324662A (en) * | 1992-05-15 | 1994-06-28 | E. R. Squibb & Sons, Inc. | Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters |
CN1322129C (zh) * | 2002-03-19 | 2007-06-20 | 三菱化学株式会社 | 新型羰基还原酶及其编码基因、以及利用它们制备光学活性醇的方法 |
AT503017B1 (de) * | 2005-12-19 | 2007-07-15 | Iep Gmbh | Verfahren zur enantioselektiven enzymatischen reduktion von hydroxyketoverbindungen |
-
2007
- 2007-11-08 CN CN2007101353918A patent/CN101429514B/zh not_active Expired - Fee Related
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101665811B (zh) * | 2009-09-04 | 2012-09-05 | 陈依军 | 一种制备s-2-羟基-4-苯基丁酸乙酯的方法 |
WO2011066755A1 (zh) * | 2009-12-01 | 2011-06-09 | Chen Yijun | (3r,5s)-二羟基-6-苄氧基己酸乙酯的合成 |
CN101880694B (zh) * | 2009-12-01 | 2014-06-11 | 陈依军 | 一种非水相制备手性3r,5s-双羟基化合物的方法 |
WO2015168867A1 (zh) * | 2014-05-06 | 2015-11-12 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
WO2015168866A1 (zh) * | 2014-05-06 | 2015-11-12 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
CN103937760A (zh) * | 2014-05-06 | 2014-07-23 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
CN103937761B (zh) * | 2014-05-06 | 2017-03-22 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
CN103937761A (zh) * | 2014-05-06 | 2014-07-23 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
CN103937759A (zh) * | 2014-05-06 | 2014-07-23 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
WO2015168868A1 (zh) * | 2014-05-06 | 2015-11-12 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶、其编码基因及应用 |
WO2015168999A1 (zh) * | 2014-05-09 | 2015-11-12 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶突变体及其应用 |
US10131883B2 (en) | 2014-05-09 | 2018-11-20 | Asymchem Laboratories (Tianjin) Co., Ltd | Diketoreductase mutant and application thereof |
CN104560907A (zh) * | 2014-12-19 | 2015-04-29 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶突变体及其应用 |
CN104560907B (zh) * | 2014-12-19 | 2017-12-22 | 凯莱英医药集团(天津)股份有限公司 | 双羰基还原酶突变体及其应用 |
CN109503542A (zh) * | 2019-01-04 | 2019-03-22 | 浙江宏元药业股份有限公司 | 一种阿托伐他汀钙中间体及其制备方法和应用 |
CN114525264A (zh) * | 2020-11-23 | 2022-05-24 | 台州华酶生物科技有限公司 | 一种高活力羰基还原酶突变体及其应用 |
CN114525264B (zh) * | 2020-11-23 | 2023-07-28 | 江苏美科生物科技有限公司 | 一种高活力羰基还原酶突变体及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101429514B (zh) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101429514B (zh) | 一种双羰基还原酶、其基因及其应用 | |
CN112301013B (zh) | 复合酶及其在制备麦角硫因中的应用 | |
Weil et al. | Structure and comparative analysis of the genes encoding component C of methyl coenzyme M reductase in the extremely thermophilic archaebacterium Methanothermus fervidus | |
TW200914610A (en) | Isopropyl alcohol-producing bacteria and method for producing isopropyl alcohol using the same | |
CN107312737A (zh) | 一种重组大肠杆菌、制备方法及合成3,4‑二羟基丁酸的方法 | |
CN112143764B (zh) | 一种生物酶催化制备布瓦西坦中间体化合物的方法 | |
US10294479B2 (en) | Candida carbonyl reductase and method for preparing (R)-lipoic acid precursor | |
CN110396508A (zh) | 源自Nocardia cyriacigeorgica的L-泛解酸内酯脱氢酶及应用 | |
CN110396507A (zh) | 源自Cnuibacter physcomitrellae的L-泛解酸内酯脱氢酶 | |
CN114075524B (zh) | 阿魏酸生产工程菌、其建立方法及其应用 | |
CN103695443B (zh) | 一种新型羰基还原酶、其基因及应用 | |
CN104673814A (zh) | 一种来自于阴沟肠杆菌的l-苏氨酸醛缩酶及其应用 | |
CN109679978B (zh) | 一种用于制备l-2-氨基丁酸的重组共表达体系及其应用 | |
CN114934062B (zh) | 一种高效表达d-阿洛酮糖3-差向异构酶的工程菌及应用 | |
CN114350630B (zh) | L-泛解酸内酯脱氢酶、突变体及其应用 | |
CN113174377B (zh) | 羰基还原酶、突变体及其在制备地尔硫卓中间体中的应用 | |
CN105950595B (zh) | (-)-γ-内酰胺酶、基因、突变体、载体及其制备与应用 | |
CN112795587B (zh) | 一株产表面活性素的大肠杆菌工程菌及其构建方法与应用 | |
CN109929853B (zh) | 嗜热菌来源的热激蛋白基因的应用 | |
CN105734027B (zh) | 一种黄嘌呤脱氢酶及其编码基因与应用 | |
CN101457217B (zh) | 具有α-苯乙醇拆分活性的嗜热脂肪酶、编码基因及其应用 | |
JP2009089649A (ja) | クロストリジウム・クルベリのジアホラーゼ遺伝子およびその利用 | |
CN112410353A (zh) | 一种fkbS基因、含其的基因工程菌及其制备方法和用途 | |
WO2019233853A1 (en) | Microorganisms and the production of fine chemicals | |
CN114875087B (zh) | 以β-吲哚基丙氨酸为底物合成5-羟基β-吲哚基丙氨酸的方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: CHANGZHOU JINLONG JIAHUA CHEMICAL CO., LTD. Free format text: FORMER OWNER: CHEN YIJUN Effective date: 20120326 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 215002 SUZHOU, JIANGSU PROVINCE TO: 213000 CHANGZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120326 Address after: 213000, Changzhou, Jiangsu Province town of new North Wei Village Riverside Industrial Park Patentee after: Changzhou Jinlong Jiahua Chemical Co., Ltd. Address before: 215002, 4, building 104, Lane 42, Lotus Lane, Suzhou, Jiangsu Patentee before: Chen Yijun |
|
C56 | Change in the name or address of the patentee |
Owner name: CHANGZHOU JINLONG BIOPHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: CHANGZHOU JINLONG JIAHUA CHEMICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 213000, Changzhou, Jiangsu Province town of new North Wei Village Riverside Industrial Park Patentee after: CHANGZHOU JINLONG BIOLOGICAL MEDICINE CO., LTD. Address before: 213000, Changzhou, Jiangsu Province town of new North Wei Village Riverside Industrial Park Patentee before: Changzhou Jinlong Jiahua Chemical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110615 Termination date: 20181108 |
|
CF01 | Termination of patent right due to non-payment of annual fee |